Purchase Short-Term Access

Is There Enough Evidence to Support Use of N-Acetylcysteine in Contrast-Induced Nephropathy?
Otavio Berwanger, MD, PhD
Annals of Internal Medicine 2008;149:215. doi:10.7326/0003-4819-149-3-200808050-00018

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.